Navigate Fool.com
Will BRLI beat
the market?
Community Rating: 4 Stars: Favorite

26.70 -0.36 (-1.33%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $27.81
Previous Close $27.06
Daily Range $26.43 - $27.81
52-Week Range $24.13 - $37.97
Market Cap $740.0M
P/E Ratio 18.66
Dividend (Yield) $0.00 (0.0%)
Volume 247,266
Average Daily Volume 272,506
Current FY EPS $1.67

How do you think BRLI
will perform against the market?

Top BRLI Bull/Bear Pitches


bo4fool (< 20)
Submitted January 6, 2011

gene testing and other niche tests coming into demand

0 Replies Reply Report this Post

ac11166 (0)
Submitted August 29, 2006

May be trading at an acquisition premium today. Premium to peers is definitely not supported by historical growth rate or risks inherent in "price taker" position with Medicare and Medicaid.

1 Replies Reply Report this Post

News & Commentary Rss Feed

Quest Diagnostics Inc.: Does This Unloved Company Deserve Your Attention

Abrupt adjustments to fee schedules and reimbursement rates in the US have created an opportunity for one of the country's largest diagnostics companies to consolidate its position. The market's overblown reaction has given investors an opportunity to buy a great company at an attractive price.

Historical Short Interest Of Stocks - New Feature Announcement

Sector Update: Healthcare Shares Flat; Allergan Upgraded to Outperform at Wells Fargo

Sector Update: Healthcare

5 Stocks That Will Probably Make Huge Moves This Week

These five stocks are all highly shorted and reporting earnings this week. Investors should buckle in for a wild ride.

Why Bio-Reference Laboratories, Tilly's, and 58.com Plunged Today

Overall, stocks generally posted modest gains in advance of the Thanksgiving holiday, but Bio-Reference Laboratories plunged 22%, Tilly’s dropped 24%, and 58.com declined 10%. Find out why these stocks did so badly today.

Why Bio-Reference Laboratories Inc. Shares Plunged

Bio-Reference shares get put through the centrifuge after releasing its preliminary fourth-quarter results and providing initial fiscal 2014 sales and net income guidance.

Here's What This Respected $2 Billion Investor Has Been Buying

It can pay off to keep an eye on disciplined, successful investors.

Why This Health Care Stock Is a Good Value

Quest Diagnostics represents good value, and its earnings growth prospects are largely over its internal execution.

Individual Healthcare Stocks Outpacing Sector Index; Bio-Reference Labs Rises After Q2 EPS, Revenue

Individual Healthcare Stocks Outpacing Sector Index; Bio-Reference Labs Rises After Q2 EPS, Revenue Beats

See More BRLI News...




Healthcare Information Services

Bio-Reference Laboratories (BRLI) Description

An independent clinical laboratory servicing the New York metropolitan area that offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. Website: http://bioreference.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks